drugset / Trial / NCT00127595
Oxaliplatin With Gemcitabine in Patients With Carcinoma of the Urothelial Tract
Non-randomizedSingle-groupOpen-labelTreatment
Summary
This is a phase II monocentric study of oxaliplatin (Ox) in combination with gemcitabine (Gem; GEMOX) in patients (pts) with advanced/metastatic transitional cell carcinoma (TCC) of the urothelial tract.
Timeline
- Start
- 2002-01
- Primary completion
- —
- Completion
- 2005-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Gemcitabine | Small molecule | — | — |
| Subject | Oxaliplatin | Small molecule | — | — |